Cite
HARVARD Citation
Tsianakas, A. et al. (2023). Real‐world effectiveness and safety of tildrakizumab in long‐term treatment of plaque psoriasis: Results from the non‐interventional, prospective, multicentre study TILOT. Journal of the European Academy of Dermatology and Venereology. pp. 85-92. [Online].